The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

With the confirmation of Robert F. Kennedy Jr. as secretary of Health and Human Services, as well as Brooke Rollins as secretary of the Department ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...

Whether you're settling into your 60s or heading into your 90s, be careful when taking medicines, herbal preparations and ...

The Trump administration is formally designating eight Latin American crime organizations as "foreign terrorist organizations ...

The creation of a “Make America Healthy Again Commission” has raised concern over Washington youths' access to medications ...

Days after Robert F. Kennedy Jr. was sworn in as HHS secretary, health agencies including the FDA, NIH and CDC saw sweeping ...

Policy makers should continue to provide clear rules of the road, increase transparency, apply more effective oversight, and ...

The study showed that medicine used to help asthma patients for more than 20 years could lessen or prevent acute allergic ...